Eye disorders affect a large number of people. Some of these, however, may be small and self-correcting, or they may be simply treated at home. Other conditions may necessitate the assistance of a professional. In the treatment of certain eye issues, eye drops and lubricants are highly suggested because they are effective and less unpleasant. These solutions and lubricants are used to treat conditions like discomfort, diabetic macular edema, dry eye, redness, refractive errors, glaucoma, conjunctivitis, itching, CMV retinitis, and age-related macular degeneration. The global Eye Drops & Lubricants market is projected to rise at a significant rate in the coming years.
Increased frequency of ophthalmic diseases and demographic change are driving the global eye drops and lubricants market. Moreover, drug discovery and development is expected to drive market expansion over the predicted period. However, the market is expected to be restrained by adverse effects associated with ophthalmic eye drops and lubricants. Furthermore, in the coming years, strict rules and regulations are likely to hamper industry expansion. However, throughout the projected period, the market is expected to be propelled by increased investment by key players in the eye drops and lubricants market in growing countries.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, Application, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Novartis International AG (Alcon Inc.), Akorn Consumer Health (TheraTears), Allergan plc, ROHTO Pharmaceutical Co., Ltd., Johnson & Johnson, Pfizer, Inc., Similasan Corporation USA, Sager Pharma Kft., Prestige Consumer Healthcare, Inc., and Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated). |
Covid-19 Impact on Eye Drops & Lubricants Market
In addition, the current Eye Drops & Lubricants Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Eye Drops & Lubricants Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Eye Drops & Lubricants Market Segment Overview
According to type, the Artificial Tears segment is expected to account for major market share in the forecast period. This is because of the rise in demand for these medications to treat artificial tears and the increase in the occurrence of dry eye syndrome across the globe. On the other hand, the Hormones segment is projected to enlarge at a high CAGR in the forthcoming years. This is owing to the high occurrence rate of dry eye in postmenopausal women. Based on application, the eye diseases segment held maximum market share due to an upsurge in the global geriatric population and the high occurrence rate of eye diseases. Moreover, the eye care segment is anticipated to grow at a higher rate in the forecast period. This is because a large number of cataracts and other eye-related operations necessitate the usage of eye drops.
Eye Drops & Lubricants Market, By Type
· Antibioticsa3
· Artificial Tears
· Hormones
· Others
Eye Drops & Lubricants Market, By Application
- Eye Diseases
- Conjunctivitis
- Dry Eye
- Glaucoma
- Refractive Errors
- Others
- Eye Care
- Others
Region-Wise, North America is anticipated to hold a major share in the Eye Drops & Lubricants market. This is because of the rise in health care investments by manufacturers and high R&D expenditure by companies for the development of these medications. Furthermore, an increase in the occurrence of ophthalmic disorders propelled the growth of the market in the region. However, the market in the Asia Pacific is anticipated to enlarge at a high CAGR in the coming years. This is due to the speedy expansion of health care infrastructure, high occurrence of ophthalmic diseases, and increase in health care initiatives by governments.
Eye Drops & Lubricants Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Eye Drops & Lubricants Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Eye Drops & Lubricants are highlighted below.
· In April 2021, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the U.S. launch of the newest addition to its innovative portfolio of dry eye products – Systane® Hydration Multi-Dose Preservative-Free (MDPF) Lubricant Eye Drops. With its proprietary HydroBoost® Technology, this new preservative-free eye drop provides extra moisture for patients with sensitive dry eyes.
Eye Drops & Lubricants Market, Key Players
· Novartis International AG (Alcon Inc.)
· Akorn Consumer Health (TheraTears)
· Allergan plc
· ROHTO Pharmaceutical Co., Ltd.
· Johnson & Johnson
· Pfizer, Inc.
· Similasan Corporation USA
· Sager Pharma Kft.
· Prestige Consumer Healthcare, Inc.
· Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the Eye Drops & Lubricants market?
Q2. Which Segments are covered in the Eye Drops & Lubricants Market report?
Q3. Which segment is projected to hold the largest share in the Eye Drops & Lubricants Market?
Q4. Which region holds the largest share in the Eye Drops & Lubricants market?
Q5. Which are the prominent players in the Eye Drops & Lubricants Market?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Eye Drops & Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Antibioticsa3
- 5.2.2. Artificial Tears
- 5.2.3. Hormones
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Eye Diseases
- 5.3.1.1. Conjunctivitis
- 5.3.1.2. Dry Eye
- 5.3.1.3. Glaucoma
- 5.3.1.4. Refractive Errors
- 5.3.1.5. Others
- 5.3.2. Eye Care
- 5.3.3. Others
- 5.3.1. Eye Diseases
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Eye Drops & Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Antibioticsa3
- 6.2.2. Artificial Tears
- 6.2.3. Hormones
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Eye Diseases
- 6.3.1.1. Conjunctivitis
- 6.3.1.2. Dry Eye
- 6.3.1.3. Glaucoma
- 6.3.1.4. Refractive Errors
- 6.3.1.5. Others
- 6.3.2. Eye Care
- 6.3.3. Others
- 6.3.1. Eye Diseases
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Eye Drops & Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Antibioticsa3
- 7.2.2. Artificial Tears
- 7.2.3. Hormones
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Eye Diseases
- 7.3.1.1. Conjunctivitis
- 7.3.1.2. Dry Eye
- 7.3.1.3. Glaucoma
- 7.3.1.4. Refractive Errors
- 7.3.1.5. Others
- 7.3.2. Eye Care
- 7.3.3. Others
- 7.3.1. Eye Diseases
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Eye Drops & Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Antibioticsa3
- 8.2.2. Artificial Tears
- 8.2.3. Hormones
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Eye Diseases
- 8.3.1.1. Conjunctivitis
- 8.3.1.2. Dry Eye
- 8.3.1.3. Glaucoma
- 8.3.1.4. Refractive Errors
- 8.3.1.5. Others
- 8.3.2. Eye Care
- 8.3.3. Others
- 8.3.1. Eye Diseases
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Eye Drops & Lubricants Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Antibioticsa3
- 9.2.2. Artificial Tears
- 9.2.3. Hormones
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Eye Diseases
- 9.3.1.1. Conjunctivitis
- 9.3.1.2. Dry Eye
- 9.3.1.3. Glaucoma
- 9.3.1.4. Refractive Errors
- 9.3.1.5. Others
- 9.3.2. Eye Care
- 9.3.3. Others
- 9.3.1. Eye Diseases
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Novartis International AG (Alcon Inc.)
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Akorn Consumer Health (TheraTears)
- 10.6. Allergan plc
- 10.7. ROHTO Pharmaceutical Co., Ltd.
- 10.8. Johnson & Johnson
- 10.9. Pfizer, Inc.
- 10.10. Similasan Corporation USA
- 10.11. Sager Pharma Kft.
- 10.12. Prestige Consumer Healthcare, Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
